Salesforce Q4 Results: Share Buybacks As Investor Worries Continue

Justin Purohit2.49K FollowersFollow5ShareSavePlay(8min)Comment(1)SummaryShares in Salesforce were initially lower following the release of Q4 results that included lower-than-expected forward guidance.Results were otherwise positive, with notable growth from its AI product, Agentforce.Ahead of the release, the stock was down about 30% to start 2026.The declines to three-year lows were viewed as an opportunity by management to initiate a +$50B buyback program.I amneutral on shares but maintain a bullish tilt.

Getty Images Software company, Salesforce (CRM), traded lower immediately following its after-hours release of Q4 results. Driving the sentiment was a combination of a weaker-than-expected forward outlook and continuing investor skepticism of the relevancy of software companiesThis article was written byJustin Purohit2.49K FollowersFollowProviding timely and quick to the punch analysis of earnings and macro-related events across various sectors, with a focus on retail and real estate. I am a licensed CPA.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.